AMBS Stock | News | Quote | Stock Forum | Sunday, October 20,

New Post Public Reply Private Reply Replies (0) Message Board

Oct 20, 2013 at 1:39 PM

Amarantus Bioscience Holdings, Inc. AMBS Company Overview

Stock Message Board http://investorshangout.com/search?q=AMBS&...mp;yt1=Go!

Last Updated: Sunday, October 20, 2013 1:38:53 PM

Amarantus Bioscience Holdings, Inc. AMBS Current Price and Quotes
Last Price 0.054
Previous Close 0.053 Open 0.055
Daily Range 0.055 - 0.053 52wk Range 0.195 - 0.0049
Volume 3,082,275 Dividend N/A
Average Vol (3m) 5,950,463 Yield N/A
Amarantus Bioscience Holdings, Inc. AMBS
Company Information

675 Almanor Ave
Sunnyvale, CA

Website: http://www.amarantus.com
Phone: 408-737-2734
Email: gerald@amarantus.com
Find us on:

Amarantus Bioscience Holdings, Inc. AMBS
Amarantus BioScience, Inc. is a development-stage biotechnology company founded in January 2008. The Company is focused on developing unique products and proprietary technologies for the potential treatment and/or diagnosis of Parkinson's disease, Alzheimer's disease, Traumatic Brain Injury, Ischemic Heart Disease and other human diseases. The Company owns the intellectual property rights to Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as tr...

Amarantus Bioscience Holdings, Inc. AMBS
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001424812
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Nov 19, 2012
Incorporated In: NV, USA
Year of Inc. 2008
Employees 3 a/o Nov 19, 2012
Company Officers/Contacts

Gerald E. Commissiong CEO, President, COO
Marc E. Faerber CFO, Treasurer, Secretary
John W. Commissiong CSO
Company Directors

Mark Benedyk
Gerald E. Commissiong
John W. Commissiong
Robert L. Harris
Company Notes

Formerly=Amarantus Bioscience, Inc. until 4-2013
Formerly=Amarantus Biosciences, Inc. until 12-2012
Formerly=Jumpkicks, Inc. until 6-2011
Service Providers

Auditor/Accountant
Silberstein Ungar, PLLC
30600 Telegraph Rd.
Suite 2175
Bingham Farms, MI, 48025
United States

Legal Counsel
Sichenzia Ross Friedman Ference LLP
61 Broadway
New York, NY, 10006
United States

Investor Relations Firm
LHA Inc.
800 Third Ave.
New York, NY, 10022
United States

Amarantus Bioscience Holdings, Inc. AMBS
AMBS Security Details

Share Structure

Market Value1 $24,892,594 a/o Oct 18, 2013
Shares Outstanding 460,973,956 a/o Aug 12, 2013
Float Not Available
Authorized Shares 1,000,000,000 a/o Nov 14, 2012
Par Value 0.001
Shareholders

Shareholders of Record 64 a/o Apr 26, 2013
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (0.00) Jun 14, 2011 Jun 06, 2011 Jun 13, 2011
Security Notes

Capital Change=shs increased by 25 for 1 split. Ex-date=06/14/2011. Rec date=06/06/2011. Pay date=06/13/2011.
Short Selling Data

Short Interest 132,524 (-72.91%)
Sep 30, 2013
Significant Failures to Deliver No
Transfer Agent(s)

VStock Transfer

Amarantus Bioscience Holdings, Inc. AMBS Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Oct 31, 2010
Total Revenue - 224 192 -
Cost of Revenue - - - -
Gross Profit - 224 192 -
Operating Expenses

Research and Development 584 1,178 490 -
Sales, General and Admin. 3,506 2,786 924 57
Non-Recurring Items - - - -
Other - - - 1
Operating Income (4,090) (3,740) (1,223) (59)
Income From Continuing Operations

Add'l Income/Expense Items 473 315 94 -
Earnings Before Interest and Tax (3,617) (3,425) (1,128) (59)
Interest Expense 1,518 1,015 79 -
Earnings Before Tax (5,136) (4,440) (1,208) (59)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (5,136) (4,440) (1,208) (59)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (5,136) (4,440) (1,208) (59)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (5,136) (4,440) (1,208) (59)

Amarantus Bioscience Holdings, Inc. AMBS Recent News

Oct 16, 2013 Amarantus to Present at 6th Annual Livingston Securities Life Science Stakeholders Summit
Oct 14, 2013 Amarantus Announces Positive Analytical Performance Data for LymPro Test(R) for Alzheimer's Disease
Oct 3, 2013 Amarantus Enters Into Letter of Intent With Renishaw for Convection-Enhanced Delivery of MANF in Parkinson's Disease
Sep 30, 2013 Amarantus BioScience President and CEO Publishes New Blog Entitled â€œFinancial Stability Heading into 2014: Laying the Groundwork for an Up-listingâ€
Sep 27, 2013 Amarantus Bioscience Holdings Announces 2nd Closing of Private Placement
Sep 24, 2013 Amarantus to Present at 2013 Aegis Healthcare Conference
Sep 13, 2013 Amarantus Appoints F. Randall Grimes, MBA as Director of Sponsored Research
Sep 9, 2013 Amarantus CEO to Present at the 15th Annual Rodman & Renshaw Global Investor Conference
Sep 6, 2013 OTC Signal Daily Stock Watch - Amarantus (OTCQB: AMBS)
Sep 4, 2013 Amarantus Bioscience Holdings Announces Private Placement of Convertible Debentures and Warrants

1
2
next >

AMBS Amarantus Bioscience Holdings, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=AMBS&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/AMBS/quote
Stock Chart http://www.otcmarkets.com/stock/AMBS/chart
Company Info http://www.otcmarkets.com/stock/AMBS/company-info
Recent News http://www.otcmarkets.com/stock/AMBS/news
Financials http://www.otcmarkets.com/stock/AMBS/financials
Filings and Disclosure http://www.otcmarkets.com/stock/AMBS/filings
Short Sales http://www.otcmarkets.com/stock/AMBS/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/AMBS/insider-transactions
Research Reports http://www.otcmarkets.com/stock/AMBS/research
Summary http://finance.yahoo.com/q?s=AMBS
Historical Prices http://finance.yahoo.com/q/hp?s=AMBS+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=AMBS
Basic Chart http://finance.yahoo.com/q/bc?s=AMBS+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=AMBS+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=AMBS+Headlines
Press Releases http://finance.yahoo.com/q/p?s=AMBS+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=AMBS+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=AMBS+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=AMBS+Industry
Major Holders http://finance.yahoo.com/q/mh?s=AMBS+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=AMBS+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=AMBS+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=AMBS
Balance Sheet http://finance.yahoo.com/q/bs?s=AMBS
Cash Flow http://finance.yahoo.com/q/cf?s=AMBS+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/AMBS
Market Watch http://www.marketwatch.com/investing/stock/AMBS
Bloomberg http://www.bloomberg.com/quote/AMBS:US
Morningstar http://quotes.morningstar.com/stock/s?t=AMBS
Bussinessweek http://investing.businessweek.com/research/st...icker=AMBS
Barchart http://www.barchart.com/quotes/stocks/AMBS
OTC Short Report http://otcshortreport.com/index.php?index=AMBS
Investopedia http://www.investopedia.com/markets/stocks/AMBS/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

AEVEX Faces 48-Hour Deadline for Investor Class Action

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

UEG's New Advisory Board: Elevating Patient Voices

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Antheia Secures $80M for Critical Medicine Onshoring

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

ASTS Faces a Legal Countdown – Investors Take Note

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Tomorrowland's Shanghai Return: An Electri-Lifesaver

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Lundbeck's Board Leadership Transitions into New Era

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...